Medical Research Network starts major global expansion programme

January 27, 2012
Business Services

Leading unique Clinical Trial Support Organisation (CTSO), Medical Research Network (MRN), has completed the first stage of a major global …

James Murdoch steps down from GSK board

January 27, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, James Murdoch

GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will …

Boehringer picture

Boehringer broadens afatinib studies

January 27, 2012
Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, afatinib

Boehringer Ingelheim is expanding the scope of its studies into afatinib to test its use against head and neck cancers. …

Amgen picture

Amgen buys Micromet for $1.2 billion

January 27, 2012
Research and Development, Sales and Marketing Amgen. Micromet, blinatumomab

Amgen is to buy German biotech firm Micromet for $1.16 billion to broaden its mid-stage pipeline and consolidate its oncology …

AXON Communications appoints Tina Hahn as vice president

January 27, 2012
Medical Communications AXON Communications, Tina Hahn

AXON Communications has announced the appointment of Dr Tina Hahn as vice president, based in Copenhagen, Denmark. In addition to …

Bristol-Myers Squibb elects Gerald Storch to board of directors

January 26, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing BMS, Gerald Storch

Bristol-Myers Squibb has announced that its board has elected Gerald Storch to serve as a member of the audit committee, …

Abbott image

Abbott strong as it prepares for spin-out

January 26, 2012
Sales and Marketing Abbott, GAAP, Humira

Abbott enjoyed a strong 2011 thanks to Humira and emerging market growth, with overall worldwide sales rising by 4.1 per …

Rebif image

Rebif approved for early use in MS

January 26, 2012
Sales and Marketing MS, Merck KGaA, Merck Serono, Rebif

The European Commission has approved an indication for multiple sclerosis treatment Rebif that treats early signs of the condition.This EC …

New Leg-Mounted Autoclaves for Designated Clean-rooms

January 26, 2012
Manufacturing and Production

Availability of stand-off legs for Priorclave’s range of bench-top autoclaves brings significant advantages to designated CAT 3 application areas providing …

CRAs spend less time on site, more time travelling

January 25, 2012
Research and Development CRAs, Clinical Research Associates, Tufts, clinical trials

A new study of how clinical research associates (CRAs) spend their time has produced some interesting and surprising results. The …

Cell-based assays to help speed toxicity studies

January 25, 2012
Research and Development Qiagen, cell-based assays, drug discovery

Use of cell-based assay technology is set to grow rapidly over the next decade, helping to speed up drug discovery …

Roche picture

Roche launches $5.7 billion hostile bid for Illumina

January 25, 2012
Research and Development, Sales and Marketing Diagnostics, Illumina, Roche

Roche has launched a hostile takeover bid for US diagnostics company Illumina. The Swiss manufacturer appears tired of waiting for …

Premier Research appoints Etienne Drouet as executive director, Oncology Europe

January 25, 2012
Business Services, Research and Development, Sales and Marketing Etienne Drouet, Premier Research

 Premier Research Group has announced the appointment of Etienne Drouet to the position of executive director, Oncology Europe.In this position, …

Gates urges investment in innovations for developing nations

January 25, 2012
Research and Development AIDS, Bill Gates, Global Fund, TB, malaria

Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …

Lansley picture

Councils given £2.2 billion for public health

January 25, 2012
Research and Development, Sales and Marketing Lansley, NHS, public health outcomes framework

The government’s new vision for public health has come under fire from observers worried that accountability for the strategy remains …

MHRA Inspections of CROs

January 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Audits, Wainwright Associates, inspectons

In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the …

Moving towards milestones: the evolving pharma – biotech relationship

January 24, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Deals, Susan Aldridge, biotech, pharma

Big pharma is going through the greatest ever wave of patent expiries, while small biotechs are finding it hard to …

Richard Barker elected to Celgene’s board of directors

January 24, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing ABPI, Celgene, Richard Barker

Celgene, the biopharma firm specialising in cancer and inflammatory diseases, has elected Richard Barker to its board of directors. Dr …

Genzyme picture

Genzyme’s Framingham site cleared by FDA

January 24, 2012
Manufacturing and Production FDA, Fabrazyme, Fabry, Genzyme

The FDA has cleared Genzyme to begin production of Fabrazyme at its new manufacturing site. The approval of the new …

Patheon gets bigger in softgels with Procaps alliance

January 24, 2012
Manufacturing and Production Patheon, Procaps, manufacturing

Contract development and manufacturing organisation Patheon has stepped up its position in the market for pharmaceutical capsules with the signing …

The Gateway to Local Adoption Series

Latest content